Navigation Links
Kessler Foundation tests Ekso exoskeletal device in 6 patients with traumatic spinal cord injury
Date:12/15/2011

West Orange, NJ. December 14, 2011. Monitored by scientists at Kessler Foundation, six people with traumatic spinal cord injuries tested Ekso, the robotic exoskeleton from Ekso Bionics that enables wheelchair users to stand and walk. The six participated in one week of preliminary testing in October 2011. Five patients have paraplegia and one has quadriplegia; they ranged in age from 27 to 45 and had durations of injury from 4 months to 2 years. This video highlights their experiences: http://www.youtube.com/user/KesslerFoundation#p/u/0/HcSEL4FDAVs

In early 2012, the research team, headed by senior research scientist Gail Forrest, PhD, will commence a clinical study in collaboration with Kessler Institute for Rehabilitation.

The week of preliminary testing provided key information that will guide protocol development, including selection criteria for individuals with spinal cord injury. "We will look at the effects of standing and walking for people with paralysis due to spinal cord injury," said Dr. Forrest. "Whether there are physiologic changes taking place, and what those changes mean in terms of functional improvement." While the study at Kessler will focus on the benefits of Ekso in rehabilitation settings, Ekso Bionics also plans to explore the potential for home and community use.


'/>"/>

Contact: Carolann Murphy
CMurphy@KesslerFoundation.org
973-324-8382
Kessler Foundation
Source:Eurekalert

Page: 1

Related biology news :

1. The Michael J. Fox Foundation awards nearly $200,000 to develop novel drugs for Parkinsons disease
2. National Science Foundation makes first awards in Sustainability Research Coordination Program
3. Peggy Lillis Foundation honors Dr. Sherwood Gorbach for career combating C. diff infection
4. National Science Foundation selects University of Colorado Denver team to study city sustainability
5. 11 women scientists announced as winners of Elsevier Foundation OWSD awards
6. Society of Interventional Radiology Foundation campaign bolstered by covidien pledge
7. Society of Interventional Radiology Foundation welcomes corporate gift from Sirtex Medical
8. The Guy Harvey Ocean Foundation awards research grant to RJ Dunlap Marine Conservation Program
9. BIDMC scientist David J. Friedman, M.D., receives award from Doris Duke Charitable Foundation
10. American Health Assistance Foundation announces latest grants for innovative vision research
11. Parkinsons Disease Foundation announces $1 million for novel studies into Parkinsons
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... 2016 First quarter 2016:   ... with the first quarter of 2015 The gross margin ... (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... unchanged, SEK 7,000-8,500 M. The operating margin for 2016 ...
(Date:4/15/2016)... , April 15, 2016 ... "Global Gait Biometrics Market 2016-2020,"  report to their ... ) , ,The global gait biometrics market ... 13.98% during the period 2016-2020. Gait ... which can be used to compute factors that ...
(Date:3/29/2016)... 2016 LegacyXChange, Inc. (OTC: ... SelectaDNA/CSI Protect are pleased to announce our successful effort ... variety of writing instruments, ensuring athletes signatures against counterfeiting ... from athletes on LegacyXChange will be assured of ongoing ... Bill Bollander , CEO states, "By ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... ... June 27, 2016 , ... Newly created ... services and solutions to the healthcare market. The company's primary focus is on ... sales and marketing strategies that are necessary to help companies efficiently bring their ...
(Date:6/24/2016)... , June 24, 2016 Epic Sciences ... detects cancers susceptible to PARP inhibitors by targeting ... cells (CTCs). The new test has already been ... in multiple cancer types. Over 230 ... damage response pathways, including PARP, ATM, ATR, DNA-PK ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) ... precise treatments and faster cures for prostate cancer. Members of the Class of ... 15 countries. Read More About the Class of 2016 ... ... ...
Breaking Biology Technology: